SCHEMBL19840915

SCHEMBL19840915

C=CCC(CC)CCNCc1ccc(C2CC2)cc1

nearest known ligand 0.33

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ SPHK1 Q9NYA1 3/20 0.33
▸ LTA4H P09960 1/20 0.33
▸ KDM1A O60341 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2D6 P10635 1/20 0.32
▸ CYP2C19 P33261 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.31
▸ CXCL12 P48061 1/20 0.31
▸ CXCR4 P61073 1/20 0.31
▸ LMNA P02545 1/20 0.31
▸ HRH4 Q9H3N8 1/20 0.31
▸ HRH3 Q9Y5N1 1/20 0.31
▸ S1PR2 O95136 1/20 0.31
▸ S1PR4 O95977 1/20 0.31
▸ S1PR1 P21453 1/20 0.31
▸ S1PR3 Q99500 1/20 0.31
▸ ACACB O00763 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19840791 0.94 CXCR4 (0.40) CXCL12CXCR4
SCHEMBL19840713 0.82 CYP1A2 (0.49) CYP1A2CYP2D6CYP2C19LMNAHRH4
SCHEMBL19840887 0.82 CHRM2 (0.46) CYP1A2CYP2D6CYP2C19SMN1; SMN2LMNA
SCHEMBL19840869 0.81 ANPEP (0.35) CYP1A2CYP2D6CYP2C19SMN1; SMN2LMNA
SCHEMBL19840866 0.81 ANPEP (0.35) CYP1A2CYP2D6CYP2C19SMN1; SMN2LMNA
SCHEMBL19841116 0.81 MEN1 (0.41) CYP1A2CYP2D6CYP2C19LMNAHRH4
SCHEMBL19840787 0.81 MEN1 (0.47) SMN1; SMN2
SCHEMBL19840793 0.80 CYP1A2 (0.34) CYP1A2CYP2D6CYP2C19SMN1; SMN2LMNA
SCHEMBL19840804 0.79 MAPK1 (0.50) SMN1; SMN2LMNA
SCHEMBL19841003 0.79 SMN1; SMN2 (0.44) CYP1A2CYP2D6SMN1; SMN2LMNAHRH4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9884832-B2 Inhibitors targeting drug-resistant influenza A THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) 2018-02-06 — — US disclosed
Send feedback